Biomedical Research in Heart Diseases

Group Leader

Núria Farré López

The Group of Biomedical Research in Heart Diseases (GREC) focuses on generating new translational research in the field of Cardiovascular Diseases, where bedside unresolved questions generate hypotheses for applied basic and clinical research with potential impact on patient management. The group works in four main areas of cardiology (coronary heart disease, valvular heart disease, arrhythmias, and cardiomyopathies/heart failure), around which it has established three main research areas: 1) identification of biomarkers of cardiovascular diseases; 2) study of the effect of ageing in heart diseases; and 3) application of new technologies in the daily management of cardiac patients.

Members

Laia Carla Belarte Tornero (Researcher)

Mercè Cladellas Capdevila (Researcher)

Paloma Garcimartín Cerezo (Researcher)

Julio Martí Almor (Researcher)

Aleksandra Mas-Stachurska (Researcher)

Lluís Molina Ferragut (Researcher)

Marta Tajes Orduña (Researcher)

Helena Tizón Marcos (Researcher)

Ermengol Vallès Gras (Researcher)

Beatriz Vaquerizo Montilla (Researcher)

Consol Ivern Díaz (Technician)

Alejandro Negrete (Technician)

Laia Yáñez Bisbe (Technician)

Marta Gimeno López (Research Assistant)

Main PublicationsOngoing Research ProjectsParticipation in Research NetworksClinical Trials Signed in 2019Outreach 

 

Main Publications

• Rodríguez-Costoya I, Tizon H, Vaquerizo B, Salvatella N, Martí-Almor J, Millán R. Coronary Lithoplasty: Initial Experience in Coronary Calcified Lesions. Rev Esp Cardiol 2019; 72(9): 788-790. FI 5.126. Q1.

• Ruiz-Bustillo S, Ivern C, Badosa N, Farré N, Marco E, Bruguera J, Cladellas M, Enjuanes C, Cainzos-Achirica M, Martí-Almor J, Comín-Colet J. Efficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trial. Eur J Cardiovasc Nurs 2019; 18(5): 366-374. FI 2.497. Q1.

• Vallès E, Benito B, Jiménez J, Cabrera S, Alcalde O, Altaba C, Guijo MA, Fan R, Martí-Almor J. Double factor single shot to diminish complications in cryoballoon ablation procedures for atrial fibrillation. J Interv Card Electrophysiol 2019; 55(1): 17-26. FI 1.534. Q4.

• Garcimartín P, Pardo Y, Verdú JM, Delgado-Hito P, Astals M, Comín J. Transcultural adaptation into Spanish of the Patient empowerment in long-term conditions questionnaire. Aten Primaria 2019; 51(1): 24-31. FI 1.346. Q3.

• Ribas N, Recasens L, Pérez-Fernández S, Bazan V, Pedro-Botet J, Ruiz-Bustillo S, Elosua R, Martí-Almor J. A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome. Clin Investig Arterioscler 2019; 31(3): 93-100.

   See all Publications

Ongoing Research Projects

• Diagnóstico y tratamiento precoz de cardiotoxicidad en pacientes onco-hematológicos en el marco de una unidad multidisciplinar

- Financing institution: Sociedad Española de Cardiología

- Period: from 2018 to 2019

- Principal investigator: Belarte Tornero, Laia Carla

• Ensayo clínico randomizado: valoración de la intervención multidisciplinar conjunta de cardiólogo y geriatra en pacientes ancianos tras ingreso reciente por insuficiencia cardiaca

- Financiang institution: Beca Primitivo de la Vega. Fundación MAPFRE

- Period: from 2017 to 2020

- Principal investigator: Farré López, Núria

   See all Projects

 

Participation in Research Networks

• CIBERCV. Estudio prospectivo multidisciplinar de nuevos indicadores fenotípicos y pronósticos en pacientes con insuficiencia cardiaca de debut (REDINSCOR III)

- Financing institution: Fondo de Investigación Sanitaria. ISCIII

- Period: from 2017 to 2020

- Principal investigator: Solé González, Eduard

 

Clinical Trials Signed in 2019

• A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

- Protocol: CSL112_3001

- Sponsor: CSL Behring LLC

- Budget: 82,336 €

- Principal investigator: Recasens Gracia, Lluís

• Estudio doble ciego, aleatorizado, controlado con placebo, con grupos paralelos de AP30663 administrado por vía intravenosa para cardioversión en pacientes con fibrilación auricular

- Protocol: AP30663 - 2001

- Sponsor: Acesion Pharma APS

- Budget: 20,915.84 €

- Principal investigator: Martí Almor, Julio

• Investigación clínica del sistema de estimulación ENO/TEO/OTO en entornos de IRM (CAPRI)

- Protocol: IBSY06

- Sponsor: Sorin CRM SAS

- Budget: 18,225 €

- Principal investigator: Martí Almor, Julio

 

Outreach

Conferences, Seminars and Courses

• Núria Farré López. III Jornada d’Actualització en la IC. IMIM, Barcelona, 19 November 2019.

 

 

 

 

 

 

 

 

C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00

info@imim.es